Related Experiment Videos
Abstract:
For surveillance purposes, Lyme disease (LD) is defined as the presence of an erythema migrans rash > or = 5 cm in diameter or laboratory confirmation of infection with Borrelia burgdorferi and at least one objective sign of musculoskeletal, neurologic, or cardiovascular disease (1). In 1982, CDC initiated surveillance for LD, and in 1990, the Council of State and Territorial Epidemiologists adopted a resolution that designated LD a nationally notifiable disease. This report summarizes surveillance data for LD in the United States during 1994.
Insights
This report summarizes 1994 U.S. surveillance data for Lyme disease (LD), a tick-borne illness defined by a characteristic rash or laboratory confirmation with symptoms. Public health efforts track LD to monitor its spread and impact.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health Surveillance
Background:
- Lyme disease (LD) surveillance is crucial for public health.
- The Centers for Disease Control and Prevention (CDC) began LD surveillance in 1982.
- LD was designated a nationally notifiable disease in 1990.
Purpose of the Study:
- To summarize Lyme disease surveillance data in the United States for the year 1994.
Main Methods:
- Surveillance data collection for Lyme disease.
- Utilizing the established definition of Lyme disease for case identification.
- Analysis of reported cases nationwide.
Main Results:
- Summary of national Lyme disease surveillance data for 1994.
- Data reflects the ongoing monitoring of this vector-borne illness.
Conclusions:
- The report provides a snapshot of Lyme disease incidence in the U.S. in 1994.
- Continued surveillance is essential for understanding and managing Lyme disease trends.